Breaking News Instant updates and real-time market news.

ALLO

Allogene Therapeutics

$25.18

-1.07 (-4.08%)

04:55
10/10/19
10/10
04:55
10/10/19
04:55

Allogene Therapeutics management to meet with William Blair

Meetings to be held in Chicago/Kansas City on October 9 and in Dallas, TX on October 10 hosted by William Blair.

  • 10

    Oct

  • 11

    Oct

  • 22

    Oct

ALLO Allogene Therapeutics
$25.18

-1.07 (-4.08%)

05/30/19
05/30/19
INITIATION
Target $25

Buy
Rubius Therapeutics, Fate Therapeutics initiated with a Buy at Guggenheim
As previously reported, Guggenheim analyst Michael Schmidt initiated Rubius Therapeutics (RUBI) and Fate Therapeutics (FATE) with a Buy rating and Allogene Therapeutics (ALLO) with a Neutral rating as part of a broader research note of 3 biotechnology stocks that developed "innovative" next-gen cell therapy platforms. The analyst has a $25 price target on Fate Therapeutics, saying the company could "leapfrog" competitors by applying its induced pluripotent stem cell, or iPSC, platform toward "engineered off-the-shelf cancer immunotherapies in a dish". While still at an early stage, Schmidt says the platform may improve upon its initial shortcomings in first and also second generation cellular cancer immunotherapies toward a broad set of therapeutic areas. The analyst is also positive on the "unique red cell therapeutics platform" of Rubius Therapeutics and its upcoming proof-of-concept data in the second half of this year, with an "extremely broad" range of potential applications including rare genetic diseases to cancer and autoimmune diseases. Schmidt also assigns $25 price target to Rubius. For Allogene Therapeutics, Schmidt says he is positive on its potential front-runner status in bringing off-the-shelf CAR-T to market, but sees much of its potential having been priced into the stock.
06/05/19
ROTH
06/05/19
INITIATION
Target $26
ROTH
Neutral
Allogene Therapeutics initiated with a Neutral at Roth Capital
Roth Capital analyst Tony Butler started Allogene Therapeutics with a Neutral rating and $26 price target. Allogene has a "strong team, a strong platform, and access to significant resources to continue development efforts," Butler tells investors in a research note. However, he believes the market has "somewhat priced" these into the stock at current levels.
08/09/19
BTIG
08/09/19
INITIATION
BTIG
Buy
Allogene Therapeutics initiated with a Buy at BTIG
08/09/19
BTIG
08/09/19
INITIATION
Target $37
BTIG
Buy
Allogene Therapeutics initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Allogene Therapeutics with a Buy rating and a price target of $37 as part of her broader research note on CAR-T cell therapy names developing "off-the-shelf" engineered cell therapeutics for oncology. The analyst notes the company is "well capitalized" with $650M in cash and equivalents with the upcoming catalysts that include the "advancement of UCART19 to potential registrational trials expected in 2020 and the presentation of initial data from the Phase 1 portion of the ongoing ALPHA trial."

TODAY'S FREE FLY STORIES

HUBS

HubSpot

$163.05

2.975 (1.86%)

09:05
10/14/19
10/14
09:05
10/14/19
09:05
Recommendations
HubSpot analyst commentary  »

Enterprise, sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

GWPH

GW Pharmaceuticals

$114.35

-3.8 (-3.22%)

09:04
10/14/19
10/14
09:04
10/14/19
09:04
Recommendations
GW Pharmaceuticals analyst commentary  »

Investor concerns related…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 05

    Nov

LAND

Gladstone Land

$11.87

(0.00%)

09:04
10/14/19
10/14
09:04
10/14/19
09:04
Hot Stocks
Gladstone Land says 'hopeful' China plan will make 'Midwest growers stronger' »

Gladstone Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

09:03
10/14/19
10/14
09:03
10/14/19
09:03
Hot Stocks
Breaking Hot Stocks news story on LeMaitre »

Admedus sells CardioCel,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ABT

Abbott

$79.61

0.11 (0.14%)

09:02
10/14/19
10/14
09:02
10/14/19
09:02
Hot Stocks
Abbott and Omada Health announce partnership »

Abbott and Omada Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

XGN

Exagen

$12.18

-1.17 (-8.76%)

09:00
10/14/19
10/14
09:00
10/14/19
09:00
Initiation
Exagen initiated  »

Exagen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOOP

Loop Industries

$10.39

0.01 (0.10%)

08:56
10/14/19
10/14
08:56
10/14/19
08:56
Initiation
Loop Industries initiated  »

Loop Industries initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$16.08

-2.56 (-13.73%)

08:55
10/14/19
10/14
08:55
10/14/19
08:55
Recommendations
Jeld-Wen analyst commentary  »

Jeld-Wen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AAPL

Apple

$236.21

6.12 (2.66%)

, BAC

Bank of America

$28.90

0.46 (1.62%)

08:55
10/14/19
10/14
08:55
10/14/19
08:55
Options
Notable open interest changes for October 14th »

Friday's total…

AAPL

Apple

$236.21

6.12 (2.66%)

BAC

Bank of America

$28.90

0.46 (1.62%)

FB

Facebook

$184.20

4.02 (2.23%)

TSLA

Tesla

$247.84

3.14 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 12

    Nov

ZG

Zillow

$29.25

0.52 (1.81%)

08:50
10/14/19
10/14
08:50
10/14/19
08:50
Recommendations
Zillow analyst commentary  »

Zillow's Flex, PA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EV

Eaton Vance

$43.47

0.875 (2.05%)

08:50
10/14/19
10/14
08:50
10/14/19
08:50
Hot Stocks
Eaton Vance reports consolidated AUM $489.7B on September 30 »

This compares to $482.8B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FLXN

Flexion

$13.37

0.125 (0.94%)

08:47
10/14/19
10/14
08:47
10/14/19
08:47
Recommendations
Flexion analyst commentary  »

Benchmark still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

, USAT

USA Technologies

$0.00

(0.00%)

08:45
10/14/19
10/14
08:45
10/14/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

USAT

USA Technologies

$0.00

(0.00%)

BYND

Beyond Meat

$131.40

-4.6 (-3.38%)

CGC

Canopy Growth

$19.42

-1.005 (-4.92%)

CHK

Chesapeake

$1.38

0.09 (6.98%)

PZZA

Papa John's

$53.16

0.32 (0.61%)

NVAX

Novavax

$4.57

0.11 (2.47%)

DXJ

WisdomTree Japan Hedged Equity Fund

$51.12

1.1 (2.20%)

PTON

Peloton

$22.40

-0.755 (-3.26%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 04

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

NFLX

Netflix

$282.89

2.47 (0.88%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Recommendations
Netflix analyst commentary  »

RBC Capital sees Q3 …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

AKTX

Akari Therapeutics

$1.81

-0.03 (-1.63%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Hot Stocks
Akari Therapeutics announces new data from ongoing Phase I/II AKC trial »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:41
10/14/19
10/14
08:41
10/14/19
08:41
Hot Stocks
Parsley Energy sees Jagged Peak Energy deal immediately accretive on key metrics »

Key Transaction…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

08:40
10/14/19
10/14
08:40
10/14/19
08:40
Initiation
Envista initiated  »

Envista initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVST

Envista

$27.87

-1.2 (-4.13%)

, DHR

Danaher

$138.78

0.1 (0.07%)

08:38
10/14/19
10/14
08:38
10/14/19
08:38
Initiation
Envista, Danaher initiated  »

Envista initiated with an…

NVST

Envista

$27.87

-1.2 (-4.13%)

DHR

Danaher

$138.78

0.1 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

KALV

KalVista

$11.00

0.27 (2.52%)

, RGNX

Regenxbio

$39.53

0.65 (1.67%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Recommendations
KalVista, Regenxbio, Kala Pharmaceuticals, Kodiak Sciences, Regeneron, Aerie Pharmaceuticals, Applied Genetic, Aldeyra, Adverum Biotechnologies, Clearside Biomedical, Ocugen analyst commentary  »

Ophthalmic therapies…

KALV

KalVista

$11.00

0.27 (2.52%)

RGNX

Regenxbio

$39.53

0.65 (1.67%)

KALA

Kala Pharmaceuticals

$3.45

-0.15 (-4.17%)

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

REGN

Regeneron

$301.02

2.56 (0.86%)

AERI

Aerie Pharmaceuticals

$20.15

2.45 (13.84%)

AGTC

Applied Genetic

$3.10

-0.08 (-2.52%)

ALDX

Aldeyra

$5.16

-0.09 (-1.71%)

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

CLSD

Clearside Biomedical

$0.76

0.0326 (4.47%)

OCGN

Ocugen

$1.51

-0.07 (-4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 24

    Oct

  • 05

    Nov

  • 06

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Hot Stocks
Parsley Energy, Jagged Peak Energy boards 'unanimously' approve merger »

The boards of directors…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HPE

HP Enterprise

$14.35

0.24 (1.70%)

08:36
10/14/19
10/14
08:36
10/14/19
08:36
Upgrade
HP Enterprise rating change  »

HP Enterprise upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

, BABA

Alibaba

$172.97

6.925 (4.17%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Genius Brands, Alibaba partner to co-produce animated children's series »

Genius Brands…

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

BABA

Alibaba

$172.97

6.925 (4.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 19

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Parsley Energy sees FY20 CapEx $1.6B-$1.9B »

Parsley (PE) remains…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CUB

Cubic

$68.86

0.58 (0.85%)

, SAIC

SAIC

$84.56

1.05 (1.26%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Cubic appoints Hilary Hageman as general counsel »

Cubic (CUB) announced the…

CUB

Cubic

$68.86

0.58 (0.85%)

SAIC

SAIC

$84.56

1.05 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

BLPH

Bellerophon

$0.45

-0.0104 (-2.26%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Bellerophon to present new data from Cohort 1 of Phase 2/3 study of INOpulse »

lpBellerophon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.